Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
68.20 INR
259.77 M INR
1.42 B INR
2.15 M
About JENBURKT PHARMACEUTICALS LTD.
Sector
CEO
Ashish Uttam Bhuta
Headquarters
Mumbai
Website
Founded
1985
ISIN
INE354A01013
FIGI
BBG000BHLXD9
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. The company was founded by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta and Harshad N. Bhuta on June 10, 1985, and is headquartered in Mumbai, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JENBURPH is 1,187.50 INR — it has increased by 0.21% in the past 24 hours. Watch JENBURKT PHARMACEUTICALS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange JENBURKT PHARMACEUTICALS LTD. stocks are traded under the ticker JENBURPH.
JENBURPH stock has risen by 19.12% compared to the previous week, the month change is a 19.41% rise, over the last year JENBURKT PHARMACEUTICALS LTD. has showed a 72.10% increase.
JENBURPH reached its all-time high on Nov 8, 2024 with the price of 1,375.00 INR, and its all-time low was 10.00 INR and was reached on Mar 22, 2004. View more price dynamics on JENBURPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JENBURPH stock is 5.84% volatile and has beta coefficient of 0.44. Track JENBURKT PHARMACEUTICALS LTD. stock price on the chart and check out the list of the most volatile stocks — is JENBURKT PHARMACEUTICALS LTD. there?
Today JENBURKT PHARMACEUTICALS LTD. has the market capitalization of 5.38 B, it has increased by 23.69% over the last week.
Yes, you can track JENBURKT PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
JENBURKT PHARMACEUTICALS LTD. is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
JENBURPH net income for the last quarter is 96.00 M INR, while the quarter before that showed 74.16 M INR of net income which accounts for 29.46% change. Track more JENBURKT PHARMACEUTICALS LTD. financial stats to get the full picture.
Yes, JENBURPH dividends are paid annually. The last dividend per share was 15.30 INR. As of today, Dividend Yield (TTM)% is 1.26%. Tracking JENBURKT PHARMACEUTICALS LTD. dividends might help you take more informed decisions.
JENBURKT PHARMACEUTICALS LTD. dividend yield was 2.22% in 2023, and payout ratio reached 25.99%. The year before the numbers were 2.16% and 25.83% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 12, 2024, the company has 752.00 employees. See our rating of the largest employees — is JENBURKT PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JENBURKT PHARMACEUTICALS LTD. EBITDA is 377.62 M INR, and current EBITDA margin is 23.73%. See more stats in JENBURKT PHARMACEUTICALS LTD. financial statements.
Like other stocks, JENBURPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JENBURKT PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JENBURKT PHARMACEUTICALS LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JENBURKT PHARMACEUTICALS LTD. stock shows the strong buy signal. See more of JENBURKT PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.